Research article · 17 Apr 2025
Research articlePublished 26 Jul 2020
Innovative Outlook for Containing COVID-19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Coronaviruses attack the respiratory tracts in humans, causing a range of illnesses from the common cold to more serious,fatal forms. Severe respiratory consequences of the COVID-19 pandemic have prompted urgent need distresssyndrome (ARDS), although not as yet well studied in respiratory virus- for novel therapies. There is no vaccine orspecific treatment for COVID-19. Current available therapies fail in severe disease where the hallmark is the cytokinestorm induced by COVID-19 in the lung. Here I consider novel approaches to improve patient’s biological resistanceto COVID-19 using stem cells and to capture the therapeutic properties of stem cells with using nanotechnology. Iam handling to inspirit a therapy for use in hopes of slowing the propagation of the disease. Cell-based approaches,primarily using mesenchymal stem cells (MSCs), have demonstrated safety and possible efficacy in patients withthe acute respiratory induced ARDS. MSCs are safe and can reverse severe critical disease with high potency mayrepresenting an entirely new biological approach to treatment. Nanotechnology could provide advanced biomaterialswhich can create a Nano scale extracellular environment capable of promoting the adhesion and proliferation ofstem cells and accelerating stem cell differentiation in a controlled manner. The investigation of stem cell based onnanotechnology could provide new methods for stem cell therapy and tissue engineering. Nanotechnology may havegreat potential to be of enormous help in the treatment of COVID-19. I am hopeful my outlook has implications for thedevelopment of a novel drug for the treatment of this unprecedented pandemic.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in World Journal of Pharmacology and Toxicology.
Editorial · 28 Mar 2025
Role of Reactive Oxygen Species in Experimental Models of Hepatorenal Toxicity
Editorial · 28 Mar 2025
Toxicological Evaluation of Novel Protein-Based Food Additives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalWorld Journal of Pharmacology and Toxicology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Laila Mahmoud Montaser”
